Browsing DCSRMF-Artículos, capítulos, libros... by Author "1eed9fa5-53da-47be-b600-4103f574c91c"

Now showing items 1-1 of 1

    • A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients 

      Toledano-Fonseca, Marta; Gómez-España, M. Auxiliadora; Élez, E.; Grávalos, C.; García-Alfonso, P.; Rodríguez, R.; Losa, F.; Alés Díaz, I.; Dopico Graña, Miguel; Valladares-Ayerbes, Manuel; García-Ortiz, M.V.; Polo, E.; Salgado, M.; Rivera, Fernando; Safont, M. J.; Salud, A.; Ruiz-Casado, A.; Tabernero, J. M.; Riesco, M. C.; Rodríguez-Ariza, Antonio; Aranda Aguilar, Enrique (Elsevier, 2023)
      The benefit of adding the antiangiogenic drug aflibercept to FOLFIRI regime in metastatic colorectal cancer (CRC) patients resistant to or progressive on an oxaliplatin-based therapy has been previously demonstrated. ...